| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States.
|
J Clin Microbiol
|
2006
|
5.97
|
|
2
|
Metal chelation and inhibition of bacterial growth in tissue abscesses.
|
Science
|
2008
|
4.55
|
|
3
|
Global gene expression in Staphylococcus aureus biofilms.
|
J Bacteriol
|
2004
|
4.46
|
|
4
|
A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence.
|
Cell Host Microbe
|
2007
|
2.55
|
|
5
|
Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover.
|
J Bacteriol
|
2006
|
2.50
|
|
6
|
Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390.
|
Microbiology
|
2006
|
2.36
|
|
7
|
Transcription Profiling of the mgrA Regulon in Staphylococcus aureus.
|
J Bacteriol
|
2006
|
2.08
|
|
8
|
Effect of mild acid on gene expression in Staphylococcus aureus.
|
J Bacteriol
|
2004
|
1.96
|
|
9
|
Characterizing the effect of the Staphylococcus aureus virulence factor regulator, SarA, on log-phase mRNA half-lives.
|
J Bacteriol
|
2006
|
1.89
|
|
10
|
A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline.
|
Antimicrob Agents Chemother
|
2005
|
1.88
|
|
11
|
The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity.
|
Mol Microbiol
|
2006
|
1.86
|
|
12
|
Comparative genomics of Staphylococcus aureus musculoskeletal isolates.
|
J Bacteriol
|
2005
|
1.85
|
|
13
|
Direct targets of CodY in Staphylococcus aureus.
|
J Bacteriol
|
2010
|
1.76
|
|
14
|
Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains.
|
Antimicrob Agents Chemother
|
2009
|
1.76
|
|
15
|
Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia.
|
Infect Immun
|
2010
|
1.59
|
|
16
|
Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis.
|
Infect Immun
|
2010
|
1.54
|
|
17
|
Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.
|
PLoS Pathog
|
2012
|
1.44
|
|
18
|
Staphylococcus aureus nonribosomal peptide secondary metabolites regulate virulence.
|
Science
|
2010
|
1.33
|
|
19
|
Characterization of the Staphylococcus aureus CidR regulon: elucidation of a novel role for acetoin metabolism in cell death and lysis.
|
Mol Microbiol
|
2006
|
1.32
|
|
20
|
The Staphylococcus aureus LytSR two-component regulatory system affects biofilm formation.
|
J Bacteriol
|
2009
|
1.31
|
|
21
|
Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
|
Curr Opin Pharmacol
|
2006
|
1.30
|
|
22
|
A new oxidative sensing and regulation pathway mediated by the MgrA homologue SarZ in Staphylococcus aureus.
|
Mol Microbiol
|
2008
|
1.25
|
|
23
|
Characterization of components of the Staphylococcus aureus mRNA degradosome holoenzyme-like complex.
|
J Bacteriol
|
2011
|
1.18
|
|
24
|
Golden pigment production and virulence gene expression are affected by metabolisms in Staphylococcus aureus.
|
J Bacteriol
|
2010
|
1.18
|
|
25
|
Messenger RNA Turnover Processes in Escherichia coli, Bacillus subtilis, and Emerging Studies in Staphylococcus aureus.
|
Int J Microbiol
|
2009
|
1.15
|
|
26
|
Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response.
|
J Bacteriol
|
2008
|
1.13
|
|
27
|
Small molecule inhibitors of Staphylococcus aureus RnpA alter cellular mRNA turnover, exhibit antimicrobial activity, and attenuate pathogenesis.
|
PLoS Pathog
|
2011
|
1.10
|
|
28
|
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
|
Antimicrob Agents Chemother
|
2009
|
1.08
|
|
29
|
Staphylococcus aureus ClpC divergently regulates capsule via sae and codY in strain newman but activates capsule via codY in strain UAMS-1 and in strain Newman with repaired saeS.
|
J Bacteriol
|
2010
|
1.08
|
|
30
|
Characterizing the effects of inorganic acid and alkaline shock on the Staphylococcus aureus transcriptome and messenger RNA turnover.
|
FEMS Immunol Med Microbiol
|
2010
|
1.03
|
|
31
|
Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis.
|
Infect Immun
|
2005
|
1.02
|
|
32
|
Identification of two small regulatory RNAs linked to virulence in Brucella abortus 2308.
|
Mol Microbiol
|
2012
|
1.01
|
|
33
|
Rsp inhibits attachment and biofilm formation by repressing fnbA in Staphylococcus aureus MW2.
|
J Bacteriol
|
2011
|
1.01
|
|
34
|
Rbf promotes biofilm formation by Staphylococcus aureus via repression of icaR, a negative regulator of icaADBC.
|
J Bacteriol
|
2009
|
1.01
|
|
35
|
The Staphylococcus aureus SrrAB two-component system promotes resistance to nitrosative stress and hypoxia.
|
MBio
|
2013
|
0.99
|
|
36
|
genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii.
|
Infect Immun
|
2012
|
0.98
|
|
37
|
Adenylate kinase release as a high-throughput-screening-compatible reporter of bacterial lysis for identification of antibacterial agents.
|
Antimicrob Agents Chemother
|
2012
|
0.97
|
|
38
|
Transcriptional profiling of Staphylococcus aureus during growth in 2 M NaCl leads to clarification of physiological roles for Kdp and Ktr K+ uptake systems.
|
MBio
|
2013
|
0.95
|
|
39
|
Design and synthesis of 2-aminothiazole based antimicrobials targeting MRSA.
|
Bioorg Med Chem Lett
|
2012
|
0.93
|
|
40
|
The staphylococcal accessory regulator, SarA, is an RNA-binding protein that modulates the mRNA turnover properties of late-exponential and stationary phase Staphylococcus aureus cells.
|
Front Cell Infect Microbiol
|
2012
|
0.92
|
|
41
|
Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes.
|
FEMS Immunol Med Microbiol
|
2012
|
0.91
|
|
42
|
Global transcriptome analysis of Staphylococcus aureus biofilms in response to innate immune cells.
|
Infect Immun
|
2013
|
0.91
|
|
43
|
Characterization of SSR42, a novel virulence factor regulatory RNA that contributes to the pathogenesis of a Staphylococcus aureus USA300 representative.
|
J Bacteriol
|
2012
|
0.89
|
|
44
|
Rot is a key regulator of Staphylococcus aureus biofilm formation.
|
Mol Microbiol
|
2015
|
0.87
|
|
45
|
Growth phase-dependent modulation of Rgg binding specificity in Streptococcus pyogenes.
|
J Bacteriol
|
2012
|
0.87
|
|
46
|
Identification of Rgg binding sites in the Streptococcus pyogenes chromosome.
|
J Bacteriol
|
2011
|
0.86
|
|
47
|
Genomics in anti-infective drug discovery--getting to endgame.
|
Curr Pharm Des
|
2002
|
0.86
|
|
48
|
The modulation of Staphylococcus aureus mRNA turnover.
|
Future Microbiol
|
2011
|
0.82
|
|
49
|
Drug-eluting cements for hard tissue repair: a comparative study using vancomycin and RNPA1000 to inhibit growth of Staphylococcus aureus.
|
J Biomater Appl
|
2013
|
0.82
|
|
50
|
Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen.
|
Antimicrob Agents Chemother
|
2013
|
0.80
|
|
51
|
RNA decay: a novel therapeutic target in bacteria.
|
Wiley Interdiscip Rev RNA
|
2012
|
0.80
|
|
52
|
Characterization of the effects of an rpoC mutation that confers resistance to the Fst peptide toxin-antitoxin system toxin.
|
J Bacteriol
|
2012
|
0.79
|
|
53
|
Target-based antimicrobial drug discovery.
|
Methods Mol Biol
|
2008
|
0.79
|
|
54
|
Diverse genetic regulon of the virulence-associated transcriptional regulator MucR in Brucella abortus 2308.
|
Infect Immun
|
2013
|
0.78
|
|
55
|
The use of molecular beacons to directly measure bacterial mRNA abundances and transcript degradation.
|
J Microbiol Methods
|
2008
|
0.78
|
|
56
|
Repurposing the antihistamine terfenadine for antimicrobial activity against Staphylococcus aureus.
|
J Med Chem
|
2014
|
0.76
|
|
57
|
Improving the treatment of musculoskeletal infections with molecular diagnostics.
|
Clin Orthop Relat Res
|
2005
|
0.76
|
|
58
|
Editorial overview: Antimicrobials.
|
Curr Opin Microbiol
|
2015
|
0.75
|